Survival of de novo stage IV breast cancer patients over three decades-Reference-Cited by-同舟云学术

Survival of de novo stage IV breast cancer patients over three decades

Published:2016-11-16 Issue:3 Volume:143 Page:509-519
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Hölzel Dieter,Eckel Renate,Bauerfeind Ingo,Baier Bernd,Beck Thomas,Braun Michael,Ettl Johannes,Hamann Ulrich,Harbeck Nadia,Kiechle Marion,Mahner Sven,Schindlbeck Christian,de Waal Johann,Engel Jutta

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-016-2306-1.pdf

Reference33 articles.

1. Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A et al (2004) Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22(16):3302–3308. doi: 10.1200/JCO.2004.08.095 22/16/3302

2. Badwe R, Hawaldar R, Nair N, Kaushik R, Parmar V, Siddique S et al (2015) Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. doi: 10.1016/s1470-2045(15)00135-7

3. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andre F et al (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)dagger. Ann Oncol 25(10):1871–1888. doi: 10.1093/annonc/mdu385

4. Criscitiello C, Giuliano M, Curigliano G, De Laurentiis M, Arpino G, Carlomagno N et al (2015) Surgery of the primary tumor in de novo metastatic breast cancer: to do or not to do? Eur J Surg Oncol. doi: 10.1016/j.ejso.2015.07.013

5. Curado M, Edwards B, Shin H, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents, Vol IX. IARC Scientific Publication No. 160

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe;European Journal of Cancer;2024-08

2. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker;Breast Cancer: Targets and Therapy;2024-07

3. Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice;Acta Oncologica;2024-05-06

4. Patterns of distant metastasis and survival outcomes in de novo metastatic breast cancer according to age groups;Frontiers in Endocrinology;2024-05-01

5. Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study;JCI Insight;2024-04-08